Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-06 DeLucia David Chief Financial Officer Shares withheld for taxes −22 $8.55 $188 4,355
2026-06-06 DeLucia David Chief Financial Officer Shares withheld for taxes −52 $6.71 $349 4,377
2026-03-06 DeLucia David Chief Financial Officer Shares withheld for taxes −60 $6.84 $410 4,429
2026-02-03 DeLucia David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +26,000 26,000
2025-12-06 DeLucia David Chief Financial Officer Shares withheld for taxes −52 $8.42 $438 4,489
2025-09-06 DeLucia David Chief Financial Officer Shares withheld for taxes −53 $12.10 $641 4,541
2025-06-06 DeLucia David Chief Financial Officer Shares withheld for taxes −51 $7.83 $399 4,594
2025-03-06 DeLucia David Chief Financial Officer Shares withheld for taxes −2,325 $0.39 $907 116,137
2025-01-09 DeLucia David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +525,000 525,000

Page 1 of 1 · 9 trades